A private hospital group and an NHS trust have ended their partnership running a cancer unit.
Hospital Corporation of America and Barking, Havering and Redbridge University Hospitals Trust ended their seven year oncology partnership at the end of January, HSJ can reveal.
A spokesman for the outer London trust, which was placed in financial special measures earlier this year, said the move was by “mutual agreement”.
The service consisted of 14 inpatient beds, six chemotherapy chairs and two consulting rooms and had its own pharmacy.
The unit was given a good rating by the Care Quality Commission in July.
The CQC report said from July 2016 to June 2017, the unit had 1,034 daycases, 404 inpatients and 295 visits to theatre. Neither HCA nor the trust would confirm what the unit’s income was for providing care while it was in operation.
The trust’s annual accounts for 2016-17 said “income generation activities” provided £5.3m of revenue, generating a surplus of £2.7m. This included HCA renting the facility and buying some medical oncology services from the trust. However, that total also included staff and patient car park charges, which are thought to amount to £1.7m.
HCA enjoys a strong position in the private healthcare sector in London, which is the single biggest element of the UK private healthcare market.
The firm runs the Harley Street Clinic, Princess Grace Hospital, The Wellington Hospital and HCA UK at The Shard.
It also has a long term partnership with The Christie Foundation Trust in Manchester to provide private cancer care.
Its lastest published accounts showed £475m in turnover, 3,200 employees and £29.2m profit before tax.
Information obtained by HSJ
Teaching trust and CCGs in formal arbitration
- Currently reading
Private provider and NHS trust end cancer partnership